• Irinotecan liposome injection regimen ‘a new reference' for metastatic pancreatic cancer

    1 day ago - By Healio

    Irinotecan liposome injection combined with 5-FU/leucovorin and oxaliplatin prolonged OS compared with nab-paclitaxel and gemcitabine as initial treatment for patients with metastatic pancreatic ductal adenocarcinoma, study results showed.
    The irinotecan liposome injection regimen, known as NALIRIFOX, also exhibited a manageable safety profile consistent with that of each treatment component, according to the findings, presented at ASCO Gastrointestinal Cancers Symposium.
    “These results support the NALIRIFOX regimen as a new reference regimen for the first-line treatment of patients with
    Read more ...